IOncology

The 2024 Annual Meeting of the European Society for Medical Oncology (ESMO) was recently held in Barcelona, Spain. As one of the top international conferences in the field of oncology, it gathered experts and scholars from around the world to share the latest research findings and explore future development directions. During this conference, several landmark studies in the field of hematologic malignancies were presented, providing valuable insights and references for current clinical practice and future research. Hematology Frontier invited Dr. Annarita Conconi from the University of Eastern Piedmont in Italy, one of the Chairs of the Mini Oral Session on Hematologic Malignancies, to comment on these landmark studies and to look ahead at the future trends in hematologic oncology.

The 2024 International Liver Cancer Association (ILCA) Conference recently held its highly anticipated awards ceremony in Rio de Janeiro, Brazil. This event attracted attention from liver cancer researchers worldwide, recognizing those who made significant contributions to the field over the past year. The ceremony aimed to further promote global collaboration and innovation in liver cancer research.

From September 26 to 28, 2024, the China Anti-Cancer Association (CACA) and the CACA Integrative Esophageal Cancer Committee hosted the 2024 CACA Integrative Esophageal Cancer Academic Conference in Hefei. This prestigious event gathered leading experts in the field of esophageal cancer from China and abroad. The topics ranged from cancer prevention, early diagnosis and treatment, standardized therapy, and integrated treatment approaches. Oncology Frontier had the opportunity to interview Dr. Renquan Zhang from The First Affiliated Hospital of Anhui Medical University (AMU) to discuss advancements in the diagnosis and treatment of esophageal cancer. Below is a summary of the interview for our readers.

From September 26 to 28, 2024, the "2024 China Anti-Cancer Association Integrated Esophageal Cancer Academic Conference" was held grandly in Hefei, hosted by the China Anti-Cancer Association (CACA) and the CACA Integrated Esophageal Cancer Committee, with five subcommittees on esophageal cancer joining forces with Anhui Medical University's First Affiliated Hospital. Alongside, the "16th China Anti-Cancer Association Esophageal Cancer Conference" also took place.

From September 22nd to 24th, 2024, the 20th International Society for Diseases of the Esophagus (ISDE) conference was grandly held in Edinburgh, Scotland. A study by Dr. Andrew Seely from the University of Ottawa's Faculty of Medicine on predictive vital sign monitoring during the perioperative period for esophageal cancer was selected for abstract presentation at the conference (Abstract No.: S19.05). Oncology Frontier conducted an exclusive interview with Prof. Seely at the conference venue to discuss his research.